Date | Time | Source | Headline | Symbol | Company |
05/15/2024 | 3:30PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ACONW | Aclarion Inc |
04/25/2024 | 9:14AM | GlobeNewswire Inc. | Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain | NASDAQ:ACONW | Aclarion Inc |
03/04/2024 | 8:00AM | GlobeNewswire Inc. | Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs | NASDAQ:ACONW | Aclarion Inc |
02/27/2024 | 3:22PM | GlobeNewswire Inc. | Aclarion Announces Closing of $3.0 Million Public Offering | NASDAQ:ACONW | Aclarion Inc |
02/26/2024 | 9:15AM | GlobeNewswire Inc. | Aclarion Announces Pricing of $3.0 Million Public Offering | NASDAQ:ACONW | Aclarion Inc |
02/05/2024 | 8:00AM | GlobeNewswire Inc. | Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership | NASDAQ:ACONW | Aclarion Inc |
01/22/2024 | 8:00AM | GlobeNewswire Inc. | Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD | NASDAQ:ACONW | Aclarion Inc |
01/17/2024 | 8:00AM | GlobeNewswire Inc. | Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution | NASDAQ:ACONW | Aclarion Inc |
01/08/2024 | 8:00AM | GlobeNewswire Inc. | Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan | NASDAQ:ACONW | Aclarion Inc |
01/02/2024 | 12:00PM | GlobeNewswire Inc. | Aclarion Announces Reverse Stock Split | NASDAQ:ACONW | Aclarion Inc |
11/27/2023 | 8:00AM | GlobeNewswire Inc. | Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams | NASDAQ:ACONW | Aclarion Inc |
11/08/2023 | 8:00AM | GlobeNewswire Inc. | Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption | NASDAQ:ACONW | Aclarion Inc |
11/06/2023 | 8:00AM | GlobeNewswire Inc. | Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD | NASDAQ:ACONW | Aclarion Inc |
11/01/2023 | 8:00AM | GlobeNewswire Inc. | Aclarion Presents at the NIH HEAL Initiative Fall Meeting | NASDAQ:ACONW | Aclarion Inc |
10/25/2023 | 8:30AM | GlobeNewswire Inc. | Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver | NASDAQ:ACONW | Aclarion Inc |
10/24/2023 | 8:45AM | GlobeNewswire Inc. | Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting | NASDAQ:ACONW | Aclarion Inc |
10/23/2023 | 7:00AM | GlobeNewswire Inc. | Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan | NASDAQ:ACONW | Aclarion Inc |
10/02/2023 | 8:00AM | GlobeNewswire Inc. | Aclarion Provides Updated Investor Presentation and Corporate Update | NASDAQ:ACONW | Aclarion Inc |
08/25/2023 | 4:10PM | GlobeNewswire Inc. | Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report | NASDAQ:ACONW | Aclarion Inc |
06/14/2023 | 11:27AM | GlobeNewswire Inc. | Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI | NASDAQ:ACONW | Aclarion Inc |
06/08/2023 | 7:30AM | GlobeNewswire Inc. | Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting | NASDAQ:ACONW | Aclarion Inc |
05/30/2023 | 7:30AM | GlobeNewswire Inc. | Aclarion Announces New Engagement with The London Clinic and London Spine Clinic | NASDAQ:ACONW | Aclarion Inc |
05/23/2023 | 7:30AM | GlobeNewswire Inc. | Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD | NASDAQ:ACONW | Aclarion Inc |
05/23/2023 | 7:00AM | GlobeNewswire Inc. | Aclarion, Inc. Announces Delayed 10-Q Filing | NASDAQ:ACONW | Aclarion Inc |
05/19/2023 | 7:30AM | GlobeNewswire Inc. | Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts | NASDAQ:ACONW | Aclarion Inc |
05/02/2023 | 7:00AM | GlobeNewswire Inc. | Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain | NASDAQ:ACONW | Aclarion Inc |
04/28/2023 | 11:20AM | GlobeNewswire Inc. | Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023 | NASDAQ:ACONW | Aclarion Inc |
04/24/2023 | 7:00AM | GlobeNewswire Inc. | Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial | NASDAQ:ACONW | Aclarion Inc |
03/07/2023 | 9:19AM | GlobeNewswire Inc. | Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor | NASDAQ:ACONW | Aclarion Inc |
02/15/2023 | 7:00AM | GlobeNewswire Inc. | Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium | NASDAQ:ACONW | Aclarion Inc |